Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News

69-Year-Old Man Diagnosed With Good Syndrome

Recurrent respiratory infections and a mediastinal mass prompted evaluation and diagnosis of Good syndrome — a thymoma-associated antibody deficiency with near-absent B cells.

Antibiotics After GI Infections Raise IBS Risk

Use of antibiotics is linked to a higher risk of developing irritable bowel syndrome, especially when antibiotics are taken for gastrointestinal infections.

AstraZeneca's Ultomiris Cuts Urine Protein in Late-stage Kidney Disease Trial

AstraZeneca said on Tuesday its rare blood disorder drug Ultomiris has met ⁠the main goal of a late-stage trial, showing a reduction in protein found in ⁠the urine of...

US FDA Approves Merck's Pill Combo to Treat HIV Infection

The U.S. Food and Drug Administration has approved Merck's once-daily, oral, combination regimen for ⁠HIV infections, the drugmaker said on Tuesday, giving patients another...

Antenatal Penicillin Allergy Test May Improve Outcomes

Penicillin allergy evaluation during pregnancy may change antibiotic selection and is associated with improved maternal and neonatal outcomes.

Does Early Formula Exposure Raise Cow’s Milk Allergy Risk?

Exposure to cow’s milk formula in the first week of life is not linked to an increased risk for cow’s milk allergy or sensitization at 1 year of age.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Latest News

Recurrent respiratory infections and a mediastinal mass prompted evaluation and diagnosis of Good syndrome — a thymoma-associated antibody deficiency with near-absent B cells.

Use of antibiotics is linked to a higher risk of developing irritable bowel syndrome, especially when antibiotics are taken for gastrointestinal infections.

AstraZeneca said on Tuesday its rare blood disorder drug Ultomiris has met ⁠the main goal of a late-stage trial, showing a reduction in protein found in ⁠the urine of...

The U.S. Food and Drug Administration has approved Merck's once-daily, oral, combination regimen for ⁠HIV infections, the drugmaker said on Tuesday, giving patients another...

Penicillin allergy evaluation during pregnancy may change antibiotic selection and is associated with improved maternal and neonatal outcomes.

Exposure to cow’s milk formula in the first week of life is not linked to an increased risk for cow’s milk allergy or sensitization at 1 year of age.

News All Time

New Drugs Are Primary Care Game Changers, but Pricey

Four recent approvals are poised to affect patient care.

Life-Extending Bile Duct Cancer Drug Cleared for NHS Use

NICE has recommended zanidatamab for HER2-positive biliary tract cancer in final draft guidance, offering patients more time and better quality of life.

SARS-CoV-2 Tied to Higher Respiratory Failure Risk Than Flu

Hospitalised adults with SARS-CoV-2, parainfluenza virus, or RSV vs influenza A/B infection experience greater acute respiratory failure, with those with SARS-CoV-2 infection having the greatest risk.

Busy? More Time-Saving Tips Won’t Help, but This Will

The clock isn’t going to slow down. The system isn’t going to fix itself. Here’s how clinicians are finding a way to live — and work — inside that reality.

Burden of ED Urologic Care Increases in Ontario

Emergency department visits and admissions for urology conditions surged in Ontario from 2007 to 2022, with longer wait times, especially for women and patients with low income.

Cost-Related Delay in Care Tied to Higher ED Use

Delaying or forgoing care for cost-related reasons is linked to increased odds of emergency department visits among Latino adults, highlighting the need to reduce financial barriers to timely care.

Physician Attire and Trust: How Much Does It Matter?

Physicians’ clothing influences how patients judge competence and approachability, with preferences varying by care setting and specialty and shaping clinical interactions.

‘Dancing’ Molecules Spur Healing in Spinal Cord Tissue

Researchers created a human spinal cord organoid, injured it, then applied an experimental therapy. What happened next was surprising and illuminating.

First AAD Guidelines Issued for Pediatric Eczema

For the first time, the American Academy of Dermatology has issued treatment guidelines specific for the control of atopic dermatitis in children.

Researchers Eye Potential Down Syndrome Fix Via Advanced Gene Editing

Researchers have developed a modified version of the CRISPR gene-editing tool that in early laboratory experiments suggests it may have the potential to “silence” the extra...

Growth Slowdown Often Seen in Suspected Cow’s Milk Allergy

Infants with gastrointestinal manifestations suggestive of cow’s milk allergy may show growth deceleration in both weight and length.

Catheter Fibrinolysis Cuts Early Risk in Pulmonary Embolism

Ultrasound-facilitated catheter-directed fibrinolysis plus anticoagulation vs anticoagulation alone reduces clinical deterioration in patients with acute intermediate-risk pulmonary embolism.

Sunflower Seed Sensitization Outpaces True Allergy in Kids

More than 80% of children sensitized to sunflower seeds and advised to avoid them can tolerate the seeds during an oral food challenge.

Dendritic Cell Strategies May Reduce Cancer Recurrence Risk

Dendritic cells within tumors may enable personalized immunotherapy strategies that reduce the risk for cancer relapses by strengthening immune memory.

Tape Strips Detect Immune Markers in Orphan Ichthyoses

Tape-strip RNA sequencing identifies shared Th17/Th22 upregulation and epidermal differentiation complex activation across four orphan ichthyoses, pilot study shows.

Adding Steroid Shows No Heart Benefit in Kawasaki Disease

Adding prednisolone to the standard treatment for Kawasaki disease in children does not lower the incidence of coronary artery lesions at 1 month after illness onset, according to a phase 3 trial.

Recommended News For You

Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.

Financial hardship common in patients with cancer

Recommended Articles For You

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology 

Unveiling the Mystery Behind Castleman Disease – Understanding Its Causes and Symptoms  

Asymptomatic Thrombocytopenia: Unraveling the Enigma of Low Platelet Counts Without Symptoms 

The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Top FDA Official Exits; SCOTUS Takes Up Obamacare Case; Texas Doc Suspended

2.

Prostate cancer death risk is higher in late teens and early 20s weight gain.

3.

Using MRD Status to Deescalate Multiple Myeloma Therapy

4.

PFS in R/R Mantle Cell Lymphoma is Improved by Ibrutinib-Venetoclax.

5.

Will a Mindfulness-Based Treatment for Depression Increase Recovery Rates?

1.

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

2.

Everything You Need To Know About Splenic Infarction – Symptoms, Treatments, And Prevention

3.

Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells

4.

Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder

5.

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

2.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

3.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot